Editas, one of the oldest CRISPR-focused biotechs, is pivoting again — to a sickle cell treatment that requires editing a ...

Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...

Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...

Opinion: Abortion providers are overwhelmed with patients from states with restrictions. Increasing abortion training for ...

At #STATSummit, three parents discussed the challenges they've faced trying to find treatments for their children with rare ...

Longtime journalist Lawrence Ingrassia embarked on a scientific odyssey to understand why members of his family were dying so ...

Karen Lynch frequently spoke of how her mother's death from suicide and her aunt's death from cancer shaped her health care ...

The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.

It is in the public’s best interest for the president and candidates to receive confidential medical care, writes ethicist ...

Most pharmaceutical executives didn't donate to political candidates in the lead-up to the election. But the ones who did ...

A coalition of 12 Philadelphia-area health systems have abandoned the use of race adjustments in four clinical tools ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...